Salute e Benessere
Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies
"We are thrilled to have licensed several technology platforms from Houston Methodist Hospital and to introduce Continuity Biosciences to the biotechnology and investment communities," said Ramakrishna Venugopalan, Co-Founder & CEO. "There is immense potential at the intersection of biopharmaceuticals and medical technologies, especially in creating combination products that enhance novel therapies. We plan to expand our technology portfolio to provide our partners with diverse strategies for delivering their treatments."
Dr. Grattoni's pioneering research, along with Continuity's licensed technologies, focuses on developing implantable nanofluidic systems. These technologies facilitate cell reprogramming, molecular sieving, immune modulation, and sustained therapeutic release over ultra-long periods. Supported by significant funding from organizations like the National Institute of Health, Department of Defense, United States Agency for International Development, Juvenile Diabetes Research Foundation (now Breakthrough T1D), ISS National Lab, and key pharmaceutical partners and foundations, these platforms have vast potential for preventing and treating chronic conditions including cancer, autoimmune, metabolic and infectious diseases. They also offer versatile applications for long-acting drug delivery and in vivo cell reprogramming systems suited for advanced cell and gene therapies.
About Continuity Biosciences, LLC
Continuity Biosciences, LLC is a forward-thinking bioscience company dedicated to developing and commercializing advanced drug delivery technologies for chronic and complex diseases. With a mission to enhance the effectiveness and delivery of therapeutic solutions, Continuity Biosciences operates from Bradenton, Florida , and
Houston, Texas . For more information, visit
www.continuitybiosciences.com .
Website link: https://continuitybiosciences.com/
LinkedIn link: https://www.linkedin.com/company/continuity-biosciences/
Maddie Brown
info@continuitybiosciences.com
View original content: https://www.prnewswire.co.uk/news-releases/continuity-biosciences-launches-to-enable-breakthrough-therapies-with-innovative-delivery-technologies-302304071.html